We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $931M
1-Year Est. Return 47.97%
This Fund
S&P 500
This Quarter Est. Return
-1.22%
1 Year Est. Return
+47.97%
3 Year Est. Return
+122.73%
5 Year Est. Return
+132.88%
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
+$7.23M
Cap. Flow
+$7.62M
Cap. Flow %
0.75%
Top 10 Hldgs %
71.39%
Holding
55
New
11
Increased
7
Reduced
25
Closed
1
Avg Time Held Equity + Options
7.6 quarters
Top 10 Avg Time Held Equity + Options
12.7 quarters
Top 20 Avg Time Held Equity + Options
11.9 quarters
Avg Time Held Equity only
8.2 quarters
Top 10 Avg Time Held Equity only
12.9 quarters
Top 20 Avg Time Held Equity only
13.3 quarters

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$19.6M
2
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$12.5M
3
NKTR icon
Nektar Therapeutics
NKTR
+$11.3M
4
AUR icon
Aurora
AUR
+$10.3M
5
GLBE icon
Global E Online
GLBE
+$7.5M

Top Sells

Rank Stock Value
1
IBKR icon
Interactive Brokers
IBKR
+$14.6M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.8M
3
PM icon
Philip Morris
PM
+$9.98M
4
SBH icon
Sally Beauty Holdings
SBH
+$7.88M
5
CTVA icon
Corteva
CTVA
+$4.99M

Sector Composition

Rank Sector Weight
1 Financials 22.55%
2 Miscellaneous 21.01%
3 Healthcare 15.88%
4 Communication Services 13.42%
5 Consumer Staples 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
B
26
Barrick Mining
B
$64.5B
$6.48M 0.64%
158,741
-6,115
-4% -$282K
2025 Q2
3 quarters
RAMP icon
27
LiveRamp
RAMP
$2.29B
$5.92M 0.59%
223,215
-8,779
-4% -$230K
2023 Q4
9 quarters
PCTY icon
28
Paylocity
PCTY
$7.85B
$3.96M 0.39%
+36,611
New +$4.49M
2026 Q1
0 quarters
TPB icon
29
Turning Point Brands
TPB
$1.15B
$3.72M 0.37%
42,859
+18,487
+76% +$2.06M
2025 Q4
1 quarter
MDLZ icon
30
Mondelez International
MDLZ
$75.8B
$3.23M 0.32%
55,974
-8,573
-13% -$496K
2021 Q2
19 quarters
SBH icon
31
Sally Beauty Holdings
SBH
$1.54B
$3.06M 0.3%
220,737
-516,513
-70% -$7.88M
2025 Q1
4 quarters
BBWI icon
32
Bath & Body Works
BBWI
$3.59B
$2.9M 0.29%
155,508
-99,103
-39% -$2.14M
2021 Q3
18 quarters
BF.A icon
33
Brown-Forman Class A
BF.A
$12.1B
$2.69M 0.27%
+100,354
New +$2.73M
2026 Q1
0 quarters
JRVR icon
34
James River Group Holdings
JRVR
$163M
$2.14M 0.21%
338,961
+215,386
+174% +$1.42M
2025 Q4
1 quarter
RSKD icon
35
Riskified
RSKD
$1.06B
$1.91M 0.19%
488,481
-25,195
-5% -$112K
2022 Q3
14 quarters
NICE icon
36
Nice
NICE
$6.82B
$1.88M 0.19%
17,091
-3,231
-16% -$369K
2025 Q4
1 quarter
IWO icon
37
CALL
iShares Russell 2000 Growth ETF
IWO
$14B
$1.38M 0.14%
+4,400
New +$1.46M
2026 Q1
0 quarters
OLED icon
38
Universal Display
OLED
$3.55B
$1.02M 0.1%
11,121
-532
-5% -$58.8K
2025 Q4
1 quarter
VRSK icon
39
Verisk Analytics
VRSK
$22B
$551K 0.05%
+2,902
New +$589K
2026 Q1
0 quarters
ENVX icon
40
Enovix
ENVX
$560M
$59.8K 0.01%
11,550
– –
2025 Q3
2 quarters
ALEC icon
41
Alector
ALEC
$214M
$41.5K ﹤0.01%
19,282
– –
2025 Q4
1 quarter
CHRS icon
42
Coherus Oncology
CHRS
$156M
$32.6K ﹤0.01%
19,282
– –
2025 Q4
1 quarter
CRBU icon
43
Caribou Biosciences
CRBU
$66.2M
$29.7K ﹤0.01%
15,627
– –
2025 Q4
1 quarter
FATE icon
44
Fate Therapeutics
FATE
$258M
$27.4K ﹤0.01%
22,853
– –
2025 Q4
1 quarter
CCCC icon
45
C4 Therapeutics
CCCC
$347M
$26.4K ﹤0.01%
10,033
– –
2025 Q4
1 quarter
PLRX icon
46
Pliant Therapeutics
PLRX
$61.3M
$23.5K ﹤0.01%
18,613
– –
2025 Q4
1 quarter
IVVD icon
47
Invivyd
IVVD
$215M
$14.3K ﹤0.01%
11,012
– –
2025 Q4
1 quarter
MIST icon
48
Milestone Pharmaceuticals
MIST
$94.3M
$12.4K ﹤0.01%
10,414
– –
2025 Q4
1 quarter
RANI icon
49
Rani Therapeutics
RANI
$93.7M
$10.9K ﹤0.01%
14,868
– –
2025 Q4
1 quarter
GUTS icon
50
Fractyl Health
GUTS
$60M
$7.74K ﹤0.01%
1,409
– –
2025 Q4
1 quarter
1
2
3

Similar funds

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $931M AUM 4.95% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
NS
Night Squared New York $930M AUM 56.46% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $933M AUM 28.32% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $929M AUM 53.07% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Bronte Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Bronte Capital Management held 55 positions worth $1.01B, up 0.72% from $1B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bronte Capital Management's Q1 2026 filing shows 11 new, 7 increased, 25 reduced and 1 closed positions. Its largest new stake was Walt Disney: 185,677 shares worth $17.9M. The largest sale was Interactive Brokers, an estimated $14.6M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Healthcare.

  • Bronte Capital Management's largest Q1 2026 buy was Walt Disney: 185,677 shares worth $17.9M.
  • Bronte Capital Management added most to BBB Foods in Q1 2026, an estimated $3.27M increase.
  • Bronte Capital Management's biggest Q1 2026 reduction was Interactive Brokers, cutting an estimated $14.6M.
  • Bronte Capital Management fully exited Fair Isaac in Q1 2026, selling an estimated $2.65M.
  • Bronte Capital Management's ten largest holdings make up 71% of its $1.01B portfolio in Q1 2026.
  • Bronte Capital Management opened 11 new positions and closed 1 in Q1 2026.
  • Bronte Capital Management's portfolio value rose 0.72% quarter-over-quarter to $1.01B.

Based on Bronte Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.